Research programme: quinolone antibiotics - Il Dong Pharmaceuticals
Alternative Names: IDQ-8006Latest Information Update: 16 Jul 2016
At a glance
- Originator Il Dong
- Class Quinolones
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in South Korea
- 29 Jun 2011 Preclinical trials in Bacterial infections in South Korea (unspecified route)